Prenetics Global (PRE)

Prenetics’ consumer platform includes IM8, a supplements brand positioned around daily health and performance; Europa, a US sports and nutrition distribution business; and CircleDNA, a genetic testing service that offers DNA-based insights directly to consumers. Through these operations, the company addresses several parts of the growing wellness market, from science-led nutritional products to health data and personalized testing.

The business is distinctive for combining consumer health brands with diagnostics heritage. CircleDNA reflects Prenetics’ roots in genetic and preventive health services, while IM8 and Europa expand its exposure to recurring consumer demand in supplements and sports nutrition. This gives the company a broader commercial profile than a single-product biotechnology or diagnostics business.

Prenetics has also adopted a digital asset treasury strategy, including an initial Bitcoin purchase of about $20 million and a board-approved plan for further Bitcoin-related treasury management. That approach makes the company unusual among listed healthcare names, as it pairs consumer health expansion with explicit exposure to Bitcoin as a corporate reserve asset. For investors, PRE represents a hybrid profile: a developing consumer healthcare platform with execution risk in competitive wellness markets, alongside balance sheet exposure to digital assets.